Last Updated: June 24, 2026

Suppliers and packagers for AZULFIDINE EN-TABS


✉ Email this page to a colleague

« Back to Dashboard


AZULFIDINE EN-TABS

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Pfizer AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073 NDA Pfizer Laboratories Div Pfizer Inc 0013-0101-10 1 BOTTLE in 1 CARTON (0013-0101-10) / 100 TABLET in 1 BOTTLE 1950-06-20
Pfizer AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073 NDA Pfizer Laboratories Div Pfizer Inc 0013-0101-30 1 BOTTLE in 1 CARTON (0013-0101-30) / 300 TABLET in 1 BOTTLE 1950-06-20
Pfizer AZULFIDINE EN-TABS sulfasalazine TABLET, DELAYED RELEASE;ORAL 007073 NDA Pfizer Laboratories Div Pfizer Inc 0013-0102-50 1 BOTTLE in 1 CARTON (0013-0102-50) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE 1950-06-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for AZULFIDINE EN-TABS

Last updated: April 26, 2026

Who Supplies AZULFIDINE EN-TABS?

What companies supply AZULFIDINE EN-TABS (sulfasalazine) for pharmacy distribution?

AZULFIDINE EN-TABS is a branded oral solid dosage form of sulfasalazine. In practice, market supply comes through the brand’s authorized manufacturer(s) and the country’s established wholesale distribution channels.

Insufficient information is available in the provided prompt to identify specific supplier companies tied to AZULFIDINE EN-TABS distribution in a specific market (e.g., US, EU, UK), or to map product-specific sourcing (manufacturer of record, labeler, and wholesale distributor) to named entities.

Because the prompt does not specify:

  • the country/market
  • the strength(s) and packaging configuration(s)
  • whether “suppliers” means manufacturers/labelers, wholesalers, or API/finished-dose contract suppliers
  • and no manufacturer/labeler identifiers (NDC, MAH, label details) are provided

a complete and accurate supplier list cannot be produced.


Key Takeaways

  • AZULFIDINE EN-TABS is sulfasalazine in an enteric-coated tablet format.
  • Named “supplier” companies cannot be stated accurately without a defined market and product label identifiers.

FAQs

1) Is AZULFIDINE EN-TABS supplied by a single company globally?

Not typically. Branded products often have different manufacturers/labelers across markets and time periods, tied to local regulatory filings and supply arrangements.

2) Does “supplier” mean API supplier or finished-dose manufacturer?

Supply can refer to either. API suppliers support upstream manufacturing; finished-dose manufacturers or labelers support commercial product availability.

3) How do wholesalers factor into “suppliers”?

Wholesalers distribute the product under supply agreements but usually are not the manufacturing source of the branded product.

4) Can generic sulfasalazine change the supplier landscape?

Yes. Generics and authorized generics can shift sourcing and distribution from branded supply chains to multiple manufacturers.

5) What is the fastest way to identify the true suppliers?

Use the product’s market-specific label identifiers (for example, NDC/GTIN in the US or national product codes elsewhere) to pull the labeler/manufacturer-of-record and map that to distribution entries.


References

No sources were provided in the prompt, and no market-specific label identifiers were supplied; therefore no citations can be produced.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.